These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34030715)

  • 1. Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway.
    Liu Q; Zhang W; Luo L; Han K; Liu R; Wei S; Guo X
    Diagn Pathol; 2021 May; 16(1):47. PubMed ID: 34030715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ-ACAP2 facilitates the progression of colorectal cancer through mediating miR-143-3p/FZD4 axis.
    Zhang G; Liu Z; Zhong J; Lin L
    Eur J Clin Invest; 2021 Dec; 51(12):e13607. PubMed ID: 34085707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00261 suppresses human colon cancer progression via sponging miR-324-3p and inactivating the Wnt/β-catenin pathway.
    Yan D; Liu W; Liu Y; Luo M
    J Cell Physiol; 2019 Dec; 234(12):22648-22656. PubMed ID: 31183860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of circ_0084043 suppresses the development of human melanoma cells through miR-429/tribbles homolog 2 axis and Wnt/β-catenin pathway.
    Chen Z; Chen J; Wa Q; He M; Wang X; Zhou J; Cen Y
    Life Sci; 2020 Feb; 243():117323. PubMed ID: 31954160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 6. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
    Tang Y; Yang P; Zhu Y; Su Y
    Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.
    Xu K; Zhang L
    Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
    Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
    Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
    Liu C; Lu Z; Liu H; Zhuang S; Guo P
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA LINC00963 promotes proliferation and migration through the miR-124-3p/FZD4 pathway in colorectal cancer.
    Zheng K; Zhang TK
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7634-7644. PubMed ID: 32744689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
    Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA TUG1 Promotes the Function in ox-LDL-Treated HA-VSMCs via miR-141-3p/ROR2 Axis.
    Tang Y; Hu J; Zhong Z; Liu Y; Wang Y
    Cardiovasc Ther; 2020; 2020():6758934. PubMed ID: 32565910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling.
    Ding D; Li C; Zhao T; Li D; Yang L; Zhang B
    Mol Cells; 2018 May; 41(5):423-435. PubMed ID: 29754471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy.
    Xia C; Li Q; Cheng X; Wu T; Gao P; Gu Y
    Bioengineered; 2022 Feb; 13(2):2450-2469. PubMed ID: 35014946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA-152-3p and regulating E2F3/MAPK8 signaling.
    Liu X; Li L; Bai J; Li L; Fan J; Fu Z; Liu J
    Cancer Sci; 2022 Jan; 113(1):109-119. PubMed ID: 34418232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.